Detalhe da pesquisa
1.
Non-endemic locoregionally advanced nasopharyngeal carcinoma: long-term outcome after induction plus concurrent chemoradiotherapy in everyday clinical practice.
Eur Arch Otorhinolaryngol
; 272(11): 3491-8, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25367705
2.
Is neck dissection necessary after induction plus concurrent chemoradiotherapy in complete responder head and neck cancer patients with pretherapy advanced nodal disease?
Ann Surg Oncol
; 20(1): 250-6, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22836557
3.
LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
Clin Epigenetics
; 14(1): 171, 2022 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36503584
4.
Pretreatment High MCV as Adverse Prognostic Marker in Nonanemic Patients with Head and Neck Cancer.
Laryngoscope
; 131(3): E836-E845, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32589769
5.
Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy.
Support Care Cancer
; 18(7): 837-45, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19727846
6.
Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.
Clin Epigenetics
; 9: 58, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572862
7.
Matched survival analysis in patients with locoregionally advanced resectable oropharyngeal carcinoma: platinum-based induction and concurrent chemoradiotherapy versus primary surgical resection.
Int J Radiat Oncol Biol Phys
; 80(1): 154-60, 2011 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20864267